Comments on: Copper Bhasma as Nanomedicine: Particle Size, Efficacy, and Liver Safety

By: Brian Cooper

Brian Cooper — Wed, 02 Dec 2026 18:31:14 +0000

It’s interesting that the authors stress the need for baseline liver tests before any course, reinforcing that even traditional preparations require modern monitoring.

By: Susan Clark

Susan Clark — Fri, 20 Nov 2026 02:51:13 +0000

From a practical standpoint, obtaining tamra bhasma only from licensed Ayurvedic pharmacies that provide XRD and ICP MS certificates seems essential for safety.

By: Tom Wilson

Tom Wilson — Sat, 07 Nov 2026 21:38:15 +0000

The animal study’s finding of mild periportal inflammation at triple the human equivalent dose gives a useful safety margin for long term use.

By: Rebecca Turner

Rebecca Turner — Mon, 26 Oct 2026 13:39:54 +0000

Reading the 2016 human study, it’s notable that serum copper stayed within normal limits after 28 days of 125 mg daily, with no ALT/AST changes.

By: Mark Bennett

Mark Bennett — Wed, 14 Oct 2026 04:52:48 +0000

I wonder if the organic coating from herb juices during shodhana could explain the slower copper ion release seen in the solubility tests.

By: Megan Parker

Megan Parker — Thu, 01 Oct 2026 14:51:39 +0000

The TEM and XRD data showing copper bhasma mainly as CuO and Cu2O nanoparticles in the 20-500 nm range really clarifies how the classical marana process creates a nanoscale product.

By: Aman Sharma

Aman Sharma — Sat, 19 Sep 2026 09:24:56 +0000

The nano-particle size discussion finally addresses how Bhasma works at the cellular level.